A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety may be found online at: T have been observed in several different types of hematolymphoid malignancies, including acute lymphoblastic and nonlymphocytic leukemias and non-Hodgkin's lymphoCytogenetic observations indicate that at least 10 different chromosomal loci may participate in translocationmediated exchanges with band 11q23.' The most common of this group is the t(4;ll) (q21;q23), which is frequently associated with biphenotypic leukemias expressing both lymphoid and myeloid surface antigens, and particularly common in leukemias of infants.'-'
chromosomes were shown to be transcriptionally active and encode potential HRX fusion protein^.^.' The predominant t( 1 1 ; 19) product originated from the derivative 1 1 chromosome and encoded a fusion protein with the features of a chimeric transcription factor consisting of an N-terminal portion of HRX fused to a novel serine/proline-rich protein from 1 9~1 3 .~ The predicted t(4;ll) products have not been completely characterized thus, it is unclear whether various HRX fusion partners might share significant similarities to suggest their respective contributions to the pathogenesis of leukemias carrying 1 lq23 translocations.
In this report we describe the product of the chromosome 4 gene (named FEL) involved in the t(4;ll) chromosomal translocation. The FEL gene is expressed normally in both B-and T-lymphoid cell lines and encodes a predicted 140-Kd protein that lacks significant homology to known proteins. Following t(4;l l), the derivative 1 1 chromosome was shown to encode a 240-Kd fusion protein containing a large C-termina1 portion of FEL fused to the N-terminal portion of HRX containing its AT hook DNA binding motifs! These features are comparable to t( 1 1 ; 19) fusion proteins and suggest that similar HRX chimeric nuclear factors may be consistently generated by 1 lq23 translocations in acute leukemias. Twenty cDNAs were isolated and characterized by nucleotide sequencing using synthetic oligonucleotides homologous to HRX or to sequences determined for the fusion partner.
HRX FUSION TRANSCRIPT IN t ( 4 ; l l ) LEUKEMIAS
Wild-type FEL cDNAs were isolated from cDNA libraries prepared from cell lines (HBI I19 and HAL-OI) lacking the t(4;I I)?.'' For library screening, fragments of t(4; I I ) fusion cDNAs that contained only chromosome 4 sequences were used as probes under high-stringency hybridization conditions. Southern and Northern. blot analyses were performed using high-stringency conditions described previously.'* Chromosome I lq23 DNA rearrangements weredetected with a 0.9-kb BamHl fragment of the HRX cDNA that spans the I lq23 fusion region of HRY' Probes for Northern blot hybridizations consisted of portions of the HRX cDNA (fragment B6) or portions of the FEL cDNA (fragments 2 and 3, see Fig 2) .
Chromosomal mapping by Southern blot and J'uorescence chromosomal in situ hybridization (FISH) . Chromosomal localization of the FEL locus was accomplished by using a 32PdCTP random primer labeled 1.6-kb probe (probe 2, see Fig 2) on Southern blots of Hindllldigested genomic DNA from normal human and Chinese hamster controls and 13 human X Chinese hamster somatic cell hybrids derived from seven independent fusion experiments'920 using methods described elsewhere.2' For finer mapping of the FEL locus. FISH was performed with two plasmids with cDNA inserts as probes (probes 2 and 3, see Fig   2) . The plasmids were biotin-I I d U T P labeled by nick-translation using commercially prepared reagents (Boehringer Mannheim, Indianapolis, IN). Hybridizations and washes were performed as previously described?' A biotin/avidin/fluorin isothyocyanate (FITC) detection system was used. Chromosomes were counterstained with propidium iodide ( I60 ng/mL, final concentration). Hybridization solutions consisted of 0.1 to 0.2 ng/pL of each probe DNA (either separately or together), 100 ng/pL each of human placental and salmon sperm DNA as competitors, 50% formamide, 2X sodium chloride sodium citrate (SSC), and 10% dextran sulfate. Metaphase spreads were obtained by standard cytogenetic procedures except that the cells were synchronized by excess BrdU (200 pg/mL, final conSouthern and Northern blotting. centration) for 17 hours and subsequently the block was released with thymidine (10 pmol/L, final concentration) for 5 hours as described. 22 A total of 76 metaphase spreads were scored for specific hybridization signals. Signals were considered specific only if two fluorescent signalscould be seen lying side-by-side, one on each chromatid of a particular chromosome. All other single signals were assumed to represent random hybridization. Metaphase spreads were examined in a Zeiss Axiophot microscope equipped with epifluorescence. Images were captured and enhanced using a cooled charge coupled device (CCD) camera (PM512; Photometrin, Tucson, AZ) and the Macintosh GeneJoin program developed by Tim Rand (Yale University, New Haven, CT). Pseudocolored images stored as PlCT files were converted to color slides, from which photographs were prepared for publication.
Computer analyses. Compilation of nucleic acid sequences, restriction enzyme, and peptide analyses were performed using the DNA Inspector IIE (Textco, West Lebanon, NH) application. Protein similarity and consensus sequence analyses were performed using lntelligenetics (Mountain View, CA) software. Similarities were determined using Quest and FastDB algorithms against keytools-I0 and SWISSPROT file banks, respectively.
RESULTS
HRX DNA rearrangements in t(4;11)-carrying leukemias. DNA isolated from leukemias or cell lines carrying t(4;ll) (92 l;q23) chromosomal translocations was analyzed by Southem blot to determine the potential involvement of the previously characterized I lq23 gene HRX. Using a 0.7-kb fragment of HRX cDNA as a probe, all cases showed at least one and in most cases two nongermline bands (Fig I A) (Fig lB, lower panel) .
Isolation of HRX fusion transcripts from a t(4;l I ) leukemia. To further characterize potential fusion transcripts, a cDNA library was constructed from mRNA isolated from t(4;11)-carrying leukemia cells (ALL no. 1, Fig 1A) . The library was screened with an HRX cDNA probe that spanned the potential fusion site (probe B6). Four types of clones were obtained ( Fig 2B) representing either wild-type HRX cDNAs or three different candidate fusion cDNAs containing non-HRX sequences fused to HRX at nucleotide no. 4220.6 All clones in the latter group showed identical sequences for 426 nucleotides beyond the site of fusion with HRX, but then diverged from one another (Fig 2B and data not shown) . Types la and lb differed at this point by the inclusion or exclusion of a single nucleotide and both open reading frames diverged and ended shortly thereafter. The observed variations suggested these clones were derived from RNAs that resulted from aberrant splicing at this site particularly because they were considerably shorter than the fusion RNA of 12 kb detected by Northern blotting. Type 2 clones contained an a p parently normal splicing pattern and were analyzed further as described below.
To confirm that the isolated cDNAs represented 4; 1 1 fusions, the non-HRX portions were regionally mapped by Southern analysis of somatic cell hybrid lines that contained defined Chromosomal mapping of the t(4;Il) fusion partner.
regions of human chromosome 4 ( Fig 3A) . Three humanspecific fragments cosegregated and were concordant with human chromosome 4q2 1-q3 1.2. All other human chromosomes were excluded by at least two discordant hybrids (data not shown).
More specific localization was obtained by fluorescence in situ hybridization to human metaphase chromosomes. Two probes (2 and 3; Fig 2 , B and C) were hybridized to the chromosomes simultaneously; 11 of 31 metaphases scored had specific signal on at least one chromosome 4 homolog. Two of these 1 1 metaphases had specific signal on both chromosome 4 homologs. Overall, using the probes separately or together, in 26 of 76 metaphases examined, specific hybridization signals were seen at 4q2 1 on at least one chromosome 4 homolog. All specific signals seen were scored as located at 4q21; there were no other specific signals on any other chromosomes. These data demonstrated that the cDNAs isolated from ALL no. 1 contained sequences derived from chromosome 4q21, in addition to HRX sequences from chro-
To further characterize the 4q2 1 fusion partner, cDNA clones corresponding to the wild-type transcript were isolated from two different libraries constructed from cell lines that lacked the t(4; 1 1). Overlapping clones showed a cDNA contig of approximately 6 kb (Fig 2, A and C) . When portions of these cDNAs were used as probes on Northern blot analyses, a major transcript of 11 kb was observed in all lymphoid cell lines examined along with a minor transcript of 11.5 kb (Fig 1B and data Analysis of the 4q21 fusion partner. (Fig 4) , suggesting that the remaining uncloned portions ofthe 1 1-kb RNA contained untranslated sequences.
Two forms of the wild-type cDNAs were isolated and found to differ at their 5' ends, perhaps as a result of differential splicing (Figs 2A and 4) .
Analysis of the open reading frames for the wild-type FEL transcript showed two predicted proteins (referred to as types 
+ + + -
A and B in Fig 4) that initiated at one of two alternative methionines in highly favorable contexts for translation initiation.*' Types A and B differed in the composition of their N terminal 12 and 5 amino acids, respectively, apparently reflecting alternative 5' exon usage. In-frame stop codons were observed upstream of each initiating ATG, indicating that the open reading frames could not extend further in the 5' direction. Data base searches indicated that the predicted proteins lacked significant similarity to previously reported proteins. Motif searches showed a guanosine triphosphate (GTP)-binding motif (residues 946 through 952), possible nuclear localization sequences (residues 670 through 674 and 709 through 7 13), and numerous potential phosphorylation sites possibly reflecting the high serine content of FEL. The predicted protein is quite hydrophilic with a net positive charge ($37 at normal pH) and also notable for its high serine (14.7%) and proline ( 1 1.3%) content.
In all cells examined, two wild-type FEL transcripts were observed, a major RNA of approximately 11 kb and a minor, slower migrating transcript of 11.5 kb (Fig 1B) . In cell lines and leukemias carrying the t(4;11) an additional transcript of 12 kb was observed (Fig 1B and data not shown) . The 12-kb RNA also hybridized with an HRX probe and migrated in a position different than the wild type HRX transcripts of 13 and 15 kb (Fig IB) . These data indicated that the 12-kb RNA contained both HRXand FEL sequences constituting a fusion RNA that crossed the t(4;11) breakpoint. Hybridization with 5' HRX and 3' FEL probes indicated that this transcript originated from the derivative 11 translocated chromosome and corresponded to the fusion cDNAs described above. Failure to detect altered transcripts with FEL probes 5' of the fusion site (data not shown) suggested that the der(4) was not expressed at significant levels or comigrated with the wild type FEL transcripts.
Chimeric HRX-FEL protein in 4;ll leukemias. a 1-trrrln.l m H p m a   ~~~~~~~~~~~~~~~c~g g g a c a g~~g~a a a g c g a g a a g a g c c~a g a a a c c q a a g c a c a q a a a c~~~9 g t~9 9~g t~~9~9~9 9 c p + 9 9~9~~C C C C~c C C 9~c a a g a C t a C C C c a q a g c a a q~~g c~~g~g t a g a~g a c g a a c~g a c c a g c c a c c c   c g c a c r g~c c 9 9~~c a c c c a c a g a a a q a g t c u c a g c a g c q g c a a c 
~A F T E R V N S S G N
Typr 8 #-t*rBinal mOqu.nc* cagcacaa~cgqgca99C~CCggc~ccgcggCcCC~agcgtgqgggcccgcc~ccccccccccccdq~aacc l 5 ~C 9 C C~9 9 C g~~C C 9 C~~g C C C C 9 9~~t C 9 9 d C O C~~C 9 C t C C C C O 9 9 C C C 9 C C C 9 d~~9 U g~C C~C C g C~~I~C C C C~~C~C C C~9 d C~C C a C C d q 1 7 5
a t t~C C 9~C C~~~~C 9~C C~~~C C C~~c t~C c c 9~a~c c c g g g g c C~a g a 9~g g c a~c~~g c a~~a c~g g g c g c c g c g c~g q a~~q g

7 5
CCCCC9CC~CCC9CCda~C99t9d9C9Cg9C9CC99C~9C~999CC9C99g9C9~~99C9CtCdC99~C99~d9~CCCCC99CtCCdCdd9CC9d~ 3 7 5 
M A A Q S &aacaqcccaqCca S L Y N D D R N L L R I R E K E R R N Q E A H Q E K E A a~tCCgtaC~aCg~~ga~~g~aaccCgcCccgaacCagag~g~aggaa~gacgcaaccagg~agcccaccaagagaaagaqqcat 4 7 5 F P E K I P L F G E P Y K T A K G D E L S S R I Q N M L G N Y E C V tcC~C9aaa~9aCC~~~~CCCttg9a~~gcccCacaggacagcdaaaggcgaCgagccqCccdgccqaacacaq~dc~cgtcgggaaaccacg~~qaaqc 515 K E F L S T K S H T H R L D A S E N R L G K P K Y P L I P D K G S qaaqqaqcccctcagtac~aaqtctcacactcatcqcc~qqacqcttccqaa~acaggccqqgaaaqccqaaacacccrttaactc~tqacaaaqq~aqc 675 S I P S S S F H T S V H H Q S I H T P A S G P L S V G N I S H N P a g C a C C~~a C C C a q C C~~C C~~a~a~C a q t q t~~~c~~C c~q C~~a C C~a c a~C c c c g~g c c r g g~c~c c c c c r g c c q g c~a c a c c a q c c a c a a t c c a a
175
K M A Q P R T E P M P S L H A K S C G P P D S Q H L T Q D R L G Q E aqaCgg~g~agCcaagaaCCgaacca~CgccaagC~C~CaCg~~aaa~gCfg~ggcccacc~acagccagc~cccgacccaggatcgccctqqccaqqa 875 G F G S S H H K K G D R R A D G D H C A S V T D S A P E R E L S P qgggCCcqgcCcCaqtcaCcacaaqaaaqqcgaccgaa9a9cC9acggagacc~ccqcgcCccqgtqacagdcccgqccccagdg~ggg~gccrtccccc 975 L I S L P S P V P P L S P I H S N Q Q T L P R T Q G S S K V H G S t t a a C C C C t C C 9 C C C C C C C C d 9 t C C C C C C C C C 9 C C d C C C~C d C a C C C C~~C C~9 C~d~C C C C C C C C C 9 9~C 9 C~~g g~~g C~g C~~g g C t C~C q q~d~C~ 1 0 1 5
S N N S K G Y C P A K S P K D L A V K V H D K E T P Q D S L V A P A gcaa~aacag~aaaggccarcgcccagccaaacccccca~ggacccagc~gcgaaagcccacgacadagagaccccccaag~caqcctgqcggcc~:tg~ 1 1 7 5 ~~a~C C~~C t C C C C a 9 a C~C C t~C a C C C~~~t C~~C~~C C C C~a a~a q t g t c q c a a c q c a g c a g a d q c c c d c g g c c c d c g c c c g g c c c a c q g a c q q t c a a
D S D S E Q T P E K P P S S S A P P S A P Q S L P E P V A S A H S S acagCqacagtqaacaaaccccagagaagccCcccCccCcaCcCgcacccccd~gCgccccdcagccccCCccagaaccagCggc~ccagcacatcccaq 1 7 1 5
~aqtg~agagt~agaaag~accdgCg~cccagacagccccCc~qacccagdgagcgagagcagCccaagcgac~gcgaagaaa~cqagcccccaqaaacc 1875
P A P E P E P P T T N K W Q L D N Y L T K V S Q P A A P P E G P R ccagcrccggaqccCqaqccccca~caac~aac~aacggcagcCggaca~ccggccqaccaa~gccagccagccagccg~cc~ccagagqqccccaqqa 1975 S T E P P R R H P E S K G S S D S A T S Q E H S E S K D P P P K S S gcacaqagcccccdcqgcggc~ccc~gagagcaagggcagc~gcqacagcqcc~cgagccagg~gc~cCccgaacccaaag~ccccccccccaaaagccc 2 0 7 5 S K A P R A P P E A P H P G R R S C Q K S P A Q Q E P P Q R Q T V caqcaaagccccccgqqccccacccga~gccccccaccccggaaagaggagccgCc~ga~gCccccggcacagcaggagcccccacaaaggcaaacc~Cc 2 1 7 5 G T K Q P K K P V K A S A R A G S R T S L Q G G R E P G L L P Y G qgdaccaaacaaccc~~aaaacccgCcaaggc~cCgcccgggcaggcCucggaccagccCgcdgg999~aa~gdgcug9gccCctCccccat~~cC 2 2 7 5 S R D Q T S K D K P K V K T K G R P R A A A S N E P K P A V P P S S
C C C g a g d C C . q a C t t C C 4~~g a C a~g C C C~a 9 g t g~d g a C 9~~~g g~C g g C C C C g~C C g C~9 C~d g C~d C 9 a a C C C d d g C C d g C a~C 9 C C C C C C C C C a 9 2 3 7 5
Q P P S Q T F P P P S L P S K S V A~Q Q K P T A Y V R P M D C Q D Q A P S E S P E L K P L P E D Y R Q Q T F E K T D L K V P A K A K L T R L K~P S Q S V E Q T Y S N E V H C V E E I L P P P L T A I H T P S T A E P S K F P F P T K D S Q H V S S V T Q N Q K Q Y D T S S K T H S N S Q Q G T S S~L E D D L Q L S D S E S A E S E S T S D S D S S S D S E S E S S S S D S E~N E P L E T E K K K B K S S L P A P S K A L S G P E P A K O N V E D R T P E H tqaqaagaagaaqcac~~gagccccccccccgccccccccaaggctcccccaggcccagdacccgcgaaggacaacgcggaqqacaggacccctqaqcac 2 4 7 5 F A L V P L T E S Q G P P H S G S G S R T S F C R S R G G P G G Q rccg~r~ccgcc~~~~cgaccgagagccaggqcccaccccacagcggcagcggcagcaggaccagtccccgccgaagccgtggcqqccca~qaqgaca~c 2 5 7 5 P Q R Q T P I A F E R H Q A A L T A Q D T P P P Q S L M V K I T L D cgcaaagac~gacCccc~CCgcccCCgagaga~cca~gcCgcCcccac~cCcaggac~CtccCccCCC~C~~agcCCgaCggtgaa~aCC~CcCt~9a 2 6 7 5
~~c g~c c c c t~g g a c a~~~~~g c c c c c c g g g a a g g g a g c c g c c a g~g g~~~g c a g a a g a c a~~c~g c~c c c g c c g~a g a a q c a c a g c c c C q a g a a 9 a 9 9 2 1 1 5 
L L S R I P Q P P G K G A A R G K Q K I N S R P P K K H S S~K R S S D S S S K L .~~G E A E R D C D N K K I R L E K E I K S a g C C C a q~C d g C t C l d g C a a g t C g g C~~~~d g~g~~~~g C g A~g
Q S S S S S S S H K E S S K T K P S R P S S Q S S K K E M L P P P P a q t C a t C C C C a C C C C C a C C C C C c C d C a a a g a~C C t t C C 4 d~~C~~~g C C c t C C d g~C C C C C~C~C~~C C C C a d A g a a g g~~a~9 C~C C C C C C~C = a C C
2915
V S S S S Q K P A K P A L K R S R R E A D T C G Q D P P K V P A V
C g C q t C C C C q t C C t C C C a g a d g C C d~C C A~g C~g C~C~C~~g~~C C~d g g C g g g~~g C~g~C d C C C 9 C g 9 C~9 g a C C C C C C~~~~g~9 C C~9 C a 9 C a 3 0 7 5
P R V N H K D S S I P K Q R R V E G K G S R S S S A D K G S S G D ccaaqaqtcaaccacaaagaccccCcc~ttcccaa~cagagaagagCagaggggaagggcCccaqaagcCcct~gcagacraggggCCcCCccqqaqata 3115
T A N P F P V P S L P N G N S K P G K P Q V K F D K Q Q A D L H X R crqcaaarcctccrccagcqccccccccqccaa~~gqc~ac~craaaccagggaaqccccaagtgaagt~~gac~aacaacaagcagacc~ccacacqaq 3 2 7 5
qqaqqcaaaaaagarqaagc~gaaagcagagccaacgaerjgacagggccgg~aagqcccccaagC~ccCgga~qccgCcCCqCcctCcaCtqdqCqcq9a 3315 a c t q c c a c a g a g c c r q a a a g c c~g c c a c c c a a g t c a g c c c a c c c c g c c c~c c c a g a a a c c~~a~a c c C c a~~a a a c c c a~a a t g~c a~c a a~a~c ~q c a a t~a a q c a c c~t~g c a c c c c t a a t a a a c a c c c c g a g a q t t c t c c c a a a g a r e r j c c c a~c a c c t t c C c c a t~c a C C~c a a~a a c~~~~t~t c t~~~~a~t g c c r c~~~c r g~~a q c t~~g t a g g g c~~c a g c~a~g t g~c q g c a g t g + g q g g a q c a q c g g g q t g g c t g c c~c C a C c a q c a c c   3 1 7 5 transcrip~ are shown in a 5 to ~~c a a a q a a t~c~~c q c t cc c~a g a c a a a t g t g t g~a~~~tc c c c~a a~a g~a~c c 9 q c g g a~~c q g c g c a c t a r a c a c q a c ac~c~c a g c a 
I A T E S E S Q S S K S A Y S V Y S E T V D L I K F X~S L K S F
3975
ATG stert codons are denoted q~t a~a a q~~c c~a~~a a a a~~~~t c a a c~q c c c~a q g c c~a t t c a a t q c c c c g q g a a c r a r c r t t q c a c a c c g g a a q c c t c a a a a a c a q~c c t t t a a~a a t~a~t t t t g g~a a a g g g c t c c q c g q a~q a c t t~t~c t c c c c c g~~c c t g g g a g a a a c a~~~g c c t a a c a a c c t c c a a c q g c c a c c c q c a~a 
1 5
cleotide (Kozak consensus23)   c c a c a a q t a a t q a a g q a c t c c a c c q t g c c c c a c c c c c t g c c a a c q a a c a~cc c c g a c a~~a c c a d~~a~t g t~~t a a~r t a~a a a a~t~a a~~~~~~ 4575 and protein (nuclear localization
E A K K~K Q K A E L M T D R V G K A F K Y L E A V L S F I E C G A I K Y S R T L N K H F E S S S K D R P G T F S M H C K K H R H T I P S F P N A F S C Q L R R V P V K C Y Q C G E Q W G G C H Y Q H P S H H P D M T S S Y V T I T S H V L T A F D L W E Q P R P S R G R I K N S L L G S D K C V H L G P Q Q Q F G G P G A L Y T T G F S A A T R I N Q N T L M E P Q V D S M P W E L F L H I G S L K N S P D
types A and B, respectively.
site is indicated with horizontal use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From Nucleotide sequence analyses of 4; I I fusion transcripts showed that the junction of HRX and FEL sequences occurred at or near amino acids I406 of HRX and 362 of FEL, the precise point undetermined because of a 5-nucleotide homology between HRXand FEL at the fusion site (Fig 5A) . Based on these observations, the HRX-FEL fusion protein had a predicted length of 2,319 amino acids. The fusion site in HRX is 34 amino acids upstream of that observed for the fusion protein described in the t( I 1;19)-carrying cell line HBl I 19. 6 The fusion site in FEL is 15 amino acids downstream to that observed in a partial 4; I I clone reported previo~sly.~ These observations suggested that translocation-associated fusion sites in HRX and FEL are not invariant but are restricted in their distribution.
DISCUSSION
The studies presented here establish a complete structure for the product of the chromosome 4 gene involved in t(4; 1 1) translocations in acute leukemias. Fusion of FEL to HRX appears to be a consistent feature of t(4; I 1) (q21;q23) translocations. Both t(4;l I)-carrying cell lines in this study contained FEL-HRX fusion transcripts of comparable size detectable with an FEL cDNA probe isolated from a t(4;l l) leukemia. In addition, partial sequence analyses of fusion cDNAs reported earlier further support the involvement of FEL (AF-4) in the RS4;l I cell line. 7 Although we detected and characterized the derivative 1 1 translocation product, other studies have reported the presence of both derivative 4 and 1 I fusion products following The FEL gene appears to be expressed normally in lymphoid cells because transcripts were detected in all cell lines examined (Fig I and data not shown) . Characterization of cDNA clones showed two alternative amino termini for FEL that appeared to result from differential utilization of 5' exons. It is not clear from our data whether the two wild-type FEL transcripts observed on Northern blots correlate with utilization of alternative 5' exons or result from other differential processing of the FEL transcript. Because it is unlikely that the minor amino terminal variations in the predicted FEL proteins confer functional differences, it is possible that the 5' FEL exons are associated with alternative promoters, but additional studies are required to address their significance and possible differential regulation.
The predicted FEL protein shares several interesting features with ENL, the previously reported protein fused to HRX after t ( I 1;19) translocations in ALL.6 Both proteins are unusually serine-and proline-rich; in fact, serines and prolines For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From constitute fully 26% of the residues in each protein. ENL and FEL are both positively charged, hydrophilic proteins with many potential phosphorylation sites. Both ENL and FEL may be nuclear proteins as each contains sequences homologous to consensus nuclear localization sequences present in known nuclear proteins.25 In addition, both proteins contain sequences that conform to a consensus GTP-binding site (GXXXXGK) suggesting possible energy requiring functions for ENL and E L . Despite these similarities, ENL and FEL are not significantly homologous to one another beyond their overall amino acid composition nor are they significantly similar to previously reported proteins preventing further functional comparisons.
The data suggest that ENL and FEL may be widely expressed, nuclear proteins without obvious DNA binding motifs. Because serine/proline-rich domains have been associated with transcriptional activator proteins, ENL and FEL may play an accessory role in some aspects of transcription regulation. Interestingly, as a result of translocations with the 1 lq23 HRYgene, large C-terminal portions of ENL and FEL are fused to the amino terminal portion of HRX that previous studies have demonstrated contains motifs (AT hooks and 'SPKK') implicated in minor groove DNA binding.6326,27 Therefore, a consistent feature of two 1 lq23 translocations is the fusion of HRX DNA binding motifs with different serine/proline-rich partners resulting in proteins that could bind DNA inappropriately and function as chimeric transcription factors.
Comparison of the chimeric products resulting from t( 1 1 ; 19) and t(4; 1 1) translocations supports the previous hypothesis6 that an important contribution of HRX to 1 lq23 translocation-associated fusion proteins is its amino terminal DNA binding domain. A common HRX DNA binding motif in both the HRX-ENL and HRX-FEL fusion proteins suggests they may deregulate a similar set of subordinate genes, although the sequence-specific DNA binding properties of the HRX motifs remain to be determined. The importance and specific contributions of each fusion partner in the t(4; 1 l), t( 1 1;19), and other 1 lq23 translocations to different leukemia phenotypes are not resolved by our studies. The compositional similarities of FEL and ENL may imply a similar leukemogenic role; however, their respective contributions and potential transcriptional properties need to be addressed in appropriate model systems.
